These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22717926)

  • 41. Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.
    Kapur NK
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):161-75. PubMed ID: 17338662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can statins alter coronary plaque composition assessed by radiofrequency backscatter intravascular ultrasound?
    Samady H; McDaniel MC
    JACC Cardiovasc Interv; 2009 Jul; 2(7):697-700. PubMed ID: 19628195
    [No Abstract]   [Full Text] [Related]  

  • 43. The Effect of Statin Therapy on Coronary Plaque Composition Using Virtual Histology Intravascular Ultrasound: A Meta-Analysis.
    Zheng G; Li Y; Huang H; Wang J; Hirayama A; Lin J
    PLoS One; 2015; 10(7):e0133433. PubMed ID: 26225936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
    Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
    Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
    Liuni A; Luca MC; Gori T; Parker JD
    J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.
    Park WJ; Jo SH; Kim SA; Kim HS; Han SJ; Choi YJ; Rhim CY
    Contemp Clin Trials; 2011 Sep; 32(5):779-82. PubMed ID: 21684353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
    Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW
    J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rosuvastatin in older patients with systolic heart failure.
    Kjekshus J; Apetrei E; Barrios V; Böhm M; Cleland JG; Cornel JH; Dunselman P; Fonseca C; Goudev A; Grande P; Gullestad L; Hjalmarson A; Hradec J; Jánosi A; Kamenský G; Komajda M; Korewicki J; Kuusi T; Mach F; Mareev V; McMurray JJ; Ranjith N; Schaufelberger M; Vanhaecke J; van Veldhuisen DJ; Waagstein F; Wedel H; Wikstrand J;
    N Engl J Med; 2007 Nov; 357(22):2248-61. PubMed ID: 17984166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention.
    de Boer SP; Brugaletta S; Garcia-Garcia HM; Simsek C; Heo JH; Lenzen MJ; Schultz C; Regar E; Zijlstra F; Boersma E; Serruys PW
    Eur Heart J; 2014 Feb; 35(5):282-9. PubMed ID: 24037276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypercholesterolemia and hypoadiponectinemia are associated with necrotic core-rich coronary plaque.
    Kojima S; Kojima S; Maruyoshi H; Nagayoshi Y; Kaikita K; Sumida H; Sugiyama S; Funahashi T; Ogawa H
    Int J Cardiol; 2011 Mar; 147(3):371-6. PubMed ID: 19896734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].
    Nohara R
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():341-4. PubMed ID: 22724226
    [No Abstract]   [Full Text] [Related]  

  • 52. Suppressive effects of standard-dose rosuvastatin therapy on the progression of coronary atherosclerosis in Japanese patients: the APOLLO study.
    Amemiya K; Yokoi H; Domei T; Shirai S; Ando K; Goya M; Iwabuchi M
    J Atheroscler Thromb; 2014; 21(12):1298-307. PubMed ID: 25100236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pitavastatin treatment on changes of plaque volume and composition according to the reduction of high-sensitivity C-reactive protein levels.
    Hong YJ; Jeong MH; Ahn Y; Kim SW; Bae JH; Hur SH; Ahn TH; Rha SW; Kim KS; Chae IH; Kim JH; Yun KH; Oh SK;
    J Cardiol; 2012 Oct; 60(4):277-82. PubMed ID: 22658699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
    McMurray JJ; Dunselman P; Wedel H; Cleland JG; Lindberg M; Hjalmarson A; Kjekshus J; Waagstein F; Apetrei E; Barrios V; Böhm M; Kamenský G; Komajda M; Mareev V; Wikstrand J;
    J Am Coll Cardiol; 2010 Oct; 56(15):1196-204. PubMed ID: 20883926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin.
    Willich SN; Englert H; Sonntag F; Völler H; Meyer-Sabellek W; Wegscheider K; Windler E; Katus H; Müller-Nordhorn J
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):180-7. PubMed ID: 19174696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology.
    Van Mieghem CA; Bruining N; Schaar JA; McFadden E; Mollet N; Cademartiri F; Mastik F; Ligthart JM; Granillo GA; Valgimigli M; Sianos G; van der Giessen WJ; Backx B; Morel MA; Van Es GA; Sawyer JD; Kaplow J; Zalewski A; van der Steen AF; de Feyter P; Serruys PW
    Int J Cardiovasc Imaging; 2005 Aug; 21(4):425-41. PubMed ID: 16047125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.
    Zhong Y; Tang H; Zeng Q; Wang X; Yi G; Meng K; Mao Y; Mao X
    Ups J Med Sci; 2012 Nov; 117(4):390-8. PubMed ID: 23009223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment with statin on atheroma regression evaluated by intravascular ultrasound with Virtual Histology (TRUTH Study): rationale and design.
    Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Michishita I;
    Circ J; 2009 Feb; 73(2):352-5. PubMed ID: 19110505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II.
    Brugaletta S; Sabaté M
    Circ J; 2014; 78(7):1531-9. PubMed ID: 24931516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Near-infrared spectroscopy for intracoronary detection of lipid-rich plaques to understand atherosclerotic plaque biology in man and guide clinical therapy.
    Erlinge D
    J Intern Med; 2015 Aug; 278(2):110-25. PubMed ID: 26096457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.